Table 1 Correlation between SNHG16 expression and clinical pathological characteristics of ESCC patients
Characteristics | All cases (%) | SNHG16 expression | P value | |
|---|---|---|---|---|
High-expression cases (n) | Low-expression cases (n) | Â | ||
Total number | 55 | Â | Â | Â |
Gender | ||||
 Male | 38 | 28 | 10 | 0.033 |
 Female | 17 | 7 | 10 | |
Age | ||||
 ≥ 60 | 50 | 31 | 19 | 0.643 |
 < 60 | 5 | 4 | 1 | |
Degree of tumour differentiation | ||||
 Cancer | 42 | 30 | 12 | 0.037 |
 HG-IEN | 3 | 2 | 1 | |
 LG-IEN | 10 | 3 | 7 | |
Tumour location | ||||
 Upper/middle | 30 | 20 | 10 | 0.779 |
 Lower | 25 | 15 | 10 | |
Tumour length | ||||
 ≥ 3 cm | 41 | 28 | 13 | 0.335 |
 < 3 cm | 14 | 7 | 7 | |
T stage | ||||
 T0 | 10 | 3 | 7 | 0.098 |
 Tis | 3 | 2 | 1 | |
 T1 | 17 | 13 | 4 | |
 T2 | 22 | 14 | 8 | |
 T3 | 3 | 3 | 0 | |
Lymphatic metastasis | ||||
 Positive | 7 | 6 | 1 | 0.402 |
 Negative | 48 | 29 | 19 | |